FOUR CLASS II RADIOLOGY DEVICES RECEIVE TIER III REVIEW STATUS
This article was originally published in The Gray Sheet
Executive SummaryFOUR CLASS II RADIOLOGY DEVICES RECEIVE TIER III REVIEW STATUS under a device "triage" list prepared by FDA's Division of Reproductive, Abdominal, Ear, Nose, and Throat, and Radiological Devices. The products are magnetic resonance spectroscopy devices, fluorescent scanners, non-image intensified fluoroscopic x-ray systems, and photofluorographic x-ray systems.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.